Biogen Exercises Option to Increase Ownership in Samsung Bioepis
28 juin 2018 16h06 HE
|
Biogen Inc.
Biogen will pay Samsung BioLogics approximately $700 million to increase its ownership in Samsung Bioepis to approximately 49.9%Transaction expected to close in the second half of 2018 CAMBRIDGE,...